Some market events can be positively fun and exciting.
That’s the case for VolitionRx Limited (NYSEMKT:VNRX) which confirmed on Monday that members of its senior management team and Board of Directors, including Chief Executive Officer, Cameron Reynolds, will ring the closing bell at the New York Stock Exchange (NYSE) 1600 EDT.
This event recognises the Company’s recent announcement of a CE mark for its Nu.QTM Colorectal Cancer Screening Triage Test from the European Union, the company said.
Only last Friday the company updated on its 2016 achievements.
It was also good to learn that the stock was 1.3% higher on Wall Street at $4.55 on Monday.
Story by ProactiveInvestors